167
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Inflammatory Burden Index and Unfavorable Prognosis After Endovascular Thrombectomy in Acute Ischemic Stroke

, , ORCID Icon, ORCID Icon, , , & show all
Pages 3009-3017 | Received 27 Apr 2023, Accepted 17 Jul 2023, Published online: 19 Jul 2023

References

  • Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–1731. doi:10.1016/S0140-6736(16)00163-X
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211
  • Huo X, Ma G, Tong X, et al. Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med. 2023;388(14):1272–1283. doi:10.1056/NEJMoa2213379
  • Hao Y, Yang D, Wang H, et al. Predictors for symptomatic intracranial hemorrhage after endovascular treatment of acute ischemic stroke. Stroke. 2017;48(5):1203–1209. doi:10.1161/STROKEAHA.116.016368
  • Deng G, Xiao J, Yu H, et al. Predictors of futile recanalization after endovascular treatment in acute ischemic stroke: a meta-analysis. J Neurointerv Surg. 2022;14(9):881–885. doi:10.1136/neurintsurg-2021-017963
  • Huang X, Yang Q, Shi X, et al. Predictors of malignant brain edema after mechanical thrombectomy for acute ischemic stroke. J Neurointerv Surg. 2019;11(10):994–998. doi:10.1136/neurintsurg-2018-014650
  • Kim JM, Bae JH, Park KY, et al. Incidence and mechanism of early neurological deterioration after endovascular thrombectomy. J Neurol. 2019;266(3):609–615. doi:10.1007/s00415-018-09173-0
  • van de Graaf RA, Samuels N, Chalos V, et al. Predictors of poor outcome despite successful endovascular treatment for ischemic stroke: results from the MR CLEAN Registry. J Neurointerv Surg. 2022;14(7):660–665. doi:10.1136/neurintsurg-2021-017726
  • Lattanzi S, Norata D, Divani AA, et al. Systemic inflammatory response index and futile recanalization in patients with ischemic stroke undergoing endovascular treatment. Brain Sci. 2021;11(9):1164. doi:10.3390/brainsci11091164
  • Macrez R, Ali C, Toutirais O, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10(5):471–480. doi:10.1016/S1474-4422(11)70066-7
  • Zang N, Lin Z, Huang K, et al. Biomarkers of unfavorable outcome in acute ischemic stroke patients with successful recanalization by endovascular thrombectomy. Cerebrovasc Dis. 2020;49(6):583–592. doi:10.1159/000510804
  • Tardif J-C, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497–2505. doi:10.1056/NEJMoa1912388
  • Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ; CANTOS Trial Group. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018;391(10118):319–328. doi:10.1016/S0140-6736(17)32814-3
  • Xie H, Ruan G, Ge Y, et al. Inflammatory burden as a prognostic biomarker for cancer. Clin Nutr. 2022;41(6):1236–1243. doi:10.1016/j.clnu.2022.04.019
  • Xie H, Ruan G, Wei L, et al. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer. J Cachexia Sarcopenia Muscle. 2023;14(2):869–878. doi:10.1002/jcsm.13199
  • Song R, Ni H, Huang J, et al. Prognostic value of inflammation-immunity-nutrition score and inflammatory burden index for hepatocellular carcinoma patients after hepatectomy. J Inflamm Res. 2022;15:6463–6479. doi:10.2147/JIR.S386407
  • Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21. doi:10.1056/NEJMoa1706442
  • Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296–2306. doi:10.1056/NEJMoa1503780
  • Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870. doi:10.1161/01.STR.20.7.864
  • Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000;355(9216):1670–1674. doi:10.1016/S0140-6736(00)02237-6
  • Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–1329. doi:10.1056/NEJMoa0804656
  • Hothorn T, Lausen B. On the exact distribution of maximally selected rank statistics. Comput Stat Data Anal. 2003;43(2):121–137. doi:10.1016/S0167-9473(02)00225-6
  • Chen Z, He Y, Su Y, Sun Y, Zhang Y, Chen H. Association of inflammatory and platelet volume markers with clinical outcome in patients with anterior circulation ischaemic stroke after endovascular thrombectomy. Neurol Res. 2021;43(6):503–510. doi:10.1080/01616412.2020.1870359
  • Pikija S, Sztriha LK, Killer-Oberpfalzer M, et al. Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke. J Neuroinflammation. 2018;15(1):319. doi:10.1186/s12974-018-1359-2
  • Feng Y, Bai X, Li W, et al. Postoperative neutrophil-lymphocyte ratio predicts unfavorable outcome of acute ischemic stroke patients who achieve complete reperfusion after thrombectomy. Front Immunol. 2022;13:963111. doi:10.3389/fimmu.2022.963111
  • Zhu H, Cao X. NLR members in inflammation-associated carcinogenesis. Cell Mol Immunol. 2017;14(5):403–405. doi:10.1038/cmi.2017.14
  • Duan Z, Wang H, Wang Z, et al. Neutrophil-lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke. Cerebrovasc Dis. 2018;45(5–6):221–227. doi:10.1159/000489401
  • Gong P, Liu Y, Gong Y, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflammation. 2021;18(1):51. doi:10.1186/s12974-021-02090-6
  • Yamamoto Y, Osanai T, Nishizaki F, et al. Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-α. Heart Vessels. 2012;27(6):624–633. doi:10.1007/s00380-011-0214-5
  • Rust R, Grönnert L, Schwab ME. Inflammation after stroke: a local rather than systemic response? Trends Neurosci. 2018;41(12):877–879. doi:10.1016/j.tins.2018.09.011
  • Seo W-K, Seok H-Y, Kim JH, et al. C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2012;21(3):181–186. doi:10.1016/j.jstrokecerebrovasdis.2010.06.002
  • Mechtouff L, Debs N, Frindel C, et al. Association of blood biomarkers of inflammation with penumbra consumption after mechanical thrombectomy in patients with acute ischemic stroke. Neurology. 2022;99(18):e2063–e2071. doi:10.1212/WNL.0000000000201038
  • Emsley HCA, Smith CJ, Georgiou RF, et al. Acute Stroke Investigators. A randomised Phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry. 2005;76(10):1366–1372. doi:10.1136/jnnp.2004.054882
  • Padma Srivastava MV, Bhasin A, Bhatia R, et al. Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial. Neurol India. 2012;60(1):23–28. doi:10.4103/0028-3886.93584
  • Zhu Z, Fu Y, Tian D, et al. Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial. Circulation. 2015;132(12):1104–1112. doi:10.1161/CIRCULATIONAHA.115.016371